| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
77,921,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
4,773,204 |
Avg
Vol: |
2,204,032 |
| 52
Week Range: |
$81.49 - $81.49 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Baldino Frank Jr |
Chairman and CEO |
• • – |
2009-12-11 |
4 |
D |
$58.94 |
$472,817 |
D/D |
(8,022) |
562,620 |
|
- |
|
| Baldino Frank Jr |
Chairman and CEO |
• • – |
2009-12-08 |
4 |
D |
$56.73 |
$1,132,558 |
D/D |
(19,964) |
570,642 |
|
- |
|
| Baldino Frank Jr |
Chairman and CEO |
• • – |
2009-12-08 |
4 |
OE |
$27.63 |
$1,132,625 |
D/D |
41,000 |
590,606 |
|
- |
|
| Vaught Jeffry L |
Exec. V.P., Chief Scientific |
• – – |
2009-12-02 |
4 |
A |
$56.07 |
$841,050 |
D/D |
15,000 |
70,939 |
|
- |
|
| Savini Carl A |
EVP, Chief Admin. Off |
• – – |
2009-12-02 |
4 |
A |
$56.07 |
$841,050 |
D/D |
15,000 |
67,528 |
|
- |
|
| Russell Lesley |
Exec. V.P., Chief Medical |
• – – |
2009-12-02 |
4 |
A |
$56.07 |
$841,050 |
D/D |
15,000 |
56,970 |
|
- |
|
| Pappert Gerald J. |
Exec. V.P., General Counsel |
• – – |
2009-12-02 |
4 |
A |
$56.07 |
$841,050 |
D/D |
15,000 |
30,000 |
|
- |
|
| Roche Robert P Jr |
Exec. VP, WW Pharm Ops |
• – – |
2009-12-02 |
4 |
A |
$56.07 |
$841,050 |
D/D |
15,000 |
55,092 |
|
- |
|
| Grebow Peter E |
Exec. V.P.,Worldwide Tech. Ops |
• – – |
2009-12-02 |
4 |
A |
$56.07 |
$841,050 |
D/D |
15,000 |
77,505 |
|
- |
|
| Buchi J Kevin |
Exec. V.P., CFO |
• – – |
2009-12-02 |
4 |
A |
$56.07 |
$841,050 |
D/D |
15,000 |
88,962 |
|
- |
|
| Baldino Frank Jr |
Chairman and CEO |
• • – |
2009-12-02 |
4 |
A |
$56.07 |
$4,485,600 |
D/D |
80,000 |
549,606 |
|
- |
|
| Baldassano Valli F. |
Exec. V.P., Chief Compliance |
• – – |
2009-12-02 |
4 |
A |
$56.07 |
$841,050 |
D/D |
15,000 |
32,813 |
|
- |
|
| Vaught Jeffry L |
Exec. V.P., Chief Scientific |
• – – |
2009-12-01 |
4/A |
D |
$55.34 |
$62,479 |
D/D |
(1,129) |
55,939 |
|
- |
|
| Vaught Jeffry L |
Exec. V.P., Chief Scientific |
• – – |
2009-12-01 |
4 |
D |
$55.34 |
$3,158,143 |
D/D |
(57,068) |
55,939 |
|
- |
|
| Savini Carl A |
EVP, Chief Admin. Off |
• – – |
2009-12-01 |
4 |
D |
$55.32 |
$84,750 |
D/D |
(1,532) |
52,528 |
|
- |
|
| Russell Lesley |
Exec. V.P., Chief Medical Off |
• – – |
2009-12-01 |
4 |
D |
$55.32 |
$6,860 |
D/D |
(124) |
41,970 |
|
- |
|
| Roche Robert P Jr |
Exec. VP, WW Pharm Ops |
• – – |
2009-12-01 |
4 |
D |
$55.32 |
$62,456 |
D/D |
(1,129) |
40,092 |
|
- |
|
| Grebow Peter E |
Exec. V.P.,Worldwide Tech. Ops |
• – – |
2009-12-01 |
4 |
D |
$55.32 |
$63,452 |
D/D |
(1,147) |
62,505 |
|
- |
|
| Buchi J Kevin |
Exec. V.P., CFO |
• – – |
2009-12-01 |
4 |
D |
$55.32 |
$68,652 |
D/D |
(1,241) |
73,962 |
|
- |
|
| Baldino Frank Jr |
Chairman and CEO |
• • – |
2009-12-01 |
4 |
D |
$55.32 |
$449,309 |
D/D |
(8,122) |
469,606 |
|
- |
|
| Baldassano Valli F. |
Exec. VP, Chief Compliance Off |
• – – |
2009-09-21 |
4 |
S |
$59.75 |
$38,838 |
D/D |
(650) |
17,813 |
|
- |
|
| Buchi J Kevin |
Exec. V.P., CFO |
• – – |
2009-06-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
453 |
75,203 |
|
- |
|
| Egan William P |
Director |
– • – |
2009-03-02 |
4 |
S |
$63.41 |
$634,903 |
D/D |
(10,000) |
0 |
|
- |
|
| Egan William P |
Director |
– • – |
2009-03-02 |
4 |
OE |
$11.19 |
$111,870 |
D/D |
10,000 |
10,000 |
|
- |
|
| Baldino Frank Jr |
Chairman and CEO |
• • – |
2009-02-02 |
4 |
D |
$77.67 |
$29,282 |
D/D |
(377) |
477,728 |
|
- |
|
491 Records found
|
|
Page 5 of 20 |
|
|
